No effect of encapsulation on the pharmacokinetics of warfarin (Q45306740)

11 December 2017

title

No effect of encapsulation on the pharmacokinetics of warfarin (English)

1 reference

11 December 2017

1 reference

Susanne Johansson

1

1 reference

11 December 2017

Lis Ohlsson

2

1 reference

11 December 2017

Helene Stenhoff

3

1 reference

11 December 2017

Karin Wåhlander

4

1 reference

11 December 2017

Marie Cullberg

5

1 reference

11 December 2017

publication date

1 April 2005

1 reference

Biopharmaceutics and Drug Disposition

11 December 2017

published in

1 reference

11 December 2017

volume

26

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

121-127

1 reference

Emerging anticoagulant drugs

11 December 2017

cites work

1 reference

Management of oral anticoagulants in the treatment of venous thromboembolism

21 January 2018

1 reference

Management of venous thromboembolism

21 January 2018

1 reference

Current anticoagulant therapy--unmet clinical needs

21 January 2018

1 reference

The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review

21 January 2018

1 reference

The pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor, are unaffected by a single dose of alcohol

21 January 2018

1 reference

No pharmacokinetic or pharmacodynamic interaction between atorvastatin and the oral direct thrombin inhibitor ximelagatran

21 January 2018

1 reference

No pharmacokinetic or pharmacodynamic interaction between digoxin and the oral direct thrombin inhibitor ximelagatran in healthy volunteers.

21 January 2018

1 reference

A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor.

21 January 2018

1 reference

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

21 January 2018

1 reference

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

21 January 2018

1 reference

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

21 January 2018

1 reference

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

21 January 2018

1 reference

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

21 January 2018

1 reference

Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe

21 January 2018

1 reference

Who needs individual bioequivalence studies for narrow therapeutic index drugs? A case for warfarin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BDD.441

1 reference

11 December 2017

1 reference